2-(2,2-Dimethylpropyl)thiazolidine-4-carboxylic acid, 95.0%, 1g

1-(CYCLOPROPYLMETHOXY)-4-FLUOROBENZENE, 95.0%, 10g

endo-3-Aminomethyl-8-boc-8-azabicyclo[3.2.1]octane, 97, 5g

Methyl 2-oxo-1,2-dihydropyrimidine-5-carboxylate hydrobromide, 95.0%, 1g

2,6-Difluoro-4-iodoanisole, 95.0%, 1g

N'-Phenyl-3-(2-phenylhydrazono)butanehydrazide, 97%, 250mg

O-Phospho-L-serine, 95.0%, 50g

ROTI®Plate90 Sab4Cla

(4-(2-Fluoropropan-2-yl)pyrimidin-5-yl)methanamine dihydrochloride, 98%, 1g

2-(Methoxymethoxy)-5-(trifluoromethylthio)phenylboronic acid, 97%, 100mg

7-BROMO-3-IODOIMIDAZO[1,2-A]PYRIDINE, 95.0%, 100mg

7-Ethynyl-dA-CEP, ≥90%, 100 mg, plastic packaging.

1,3,2-Dioxaborolane, 4,4,5,5-tetramethyl-2-[(1E)-2-(trimethylsilyl)ethenyl]-, 95%, 5g